Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

An arthritis drug helped a person with severe hair loss regrow their hair.

AH-001 could be a safer and more effective treatment for hair loss.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

Peptide nanoparticles can effectively deliver CRISPR-Cas9 to target KRAS mutations in cancer.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

DK peptides can reduce hair loss by inhibiting the 5α-reductase enzyme and have antioxidant effects.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Tofacitinib helped a man with alopecia totalis regrow all his hair.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Dutasteride may help shrink prostate cancer tumors.

Dutasteride improved both hair loss and acne in two young men.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.